1Voormolen N, Nooedzij M, Grootendorst DC, et al.PREPARE study group:High plasma phosphate as a risk factor for decline in renal function and mortality in predialysis patients.Nephrol Dial Transplant,2007,22:2909-2916. 被引量：1
2Adeney KL,Siscovick DS,Ix JH,et al.Association of serum phosphate with vascular and valvular calcification in moderate CKD.J Am Soc Nephrol,2009,20:381-387. 被引量：1
3Yamada K,Fujimoto S,Nishiura R,et al.Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis.Nephrol Dial Transplant,2007,22:2032-2037. 被引量：1
4Block GA,Spiegel DM,Ehrlich J,et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.Kidney Int,2005,68: 1815-1824. 被引量：1
5Nikolaev VG. Peroral application of synthetic activated charcoal in USSR.Biomater Artif Cells Artif Organs,1990,18:555-568. 被引量：1
6Sanaka T,Akizawa T,Koide K,et al.Protective effect of an oral adsorbent on renal function in chronic renal failure:determinants of its efficacy in diabetic nephropathy.Ther Apher Dial,2004,8:232-240. 被引量：1
7National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.Am J Kidney Dis,2003,42 Suppl 3:S1-S201. 被引量：1
8Pederson JA.Relief of idiopathic generalized pruritus in dialysis patients treated with activated oral charcoal.Ann Intern Med,1980,93:446-448. 被引量：1
9Giovannetti S,Barsotti G,Cupisti A,et al.Oral activated charcoal in patients with uremic pruritus.Nephron,1995,70:193-196. 被引量：1
